Sumoylation of FOXP2 Regulates Motor Function and Vocal Communication Through Purkinje Cell Development

Biological Psychiatry

Volumn 81, Issue 3, 2017, Pages 220-230

  Usui, Noriyoshi ^a   Co, Marissa ^a   Harper, Matthew ^a   Rieger, Michael A ^b   Dougherty, Joseph D ^b   Konopka, Genevieve ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebellum; FOXP2; Motor function; Purkinje cells; Sumoylation; Vocal communication

Indexed keywords

TRANSCRIPTION FACTOR FOXP2; FORKHEAD TRANSCRIPTION FACTOR; FOXP2 PROTEIN, MOUSE; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN REGION; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR DISTRIBUTION; CEREBELLUM; CEREBELLUM CELL; CONTROLLED STUDY; DENDRITIC CELL; ELECTROPORATION; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; LANGUAGE DISABILITY; LOCOMOTION; MENTAL DISEASE; MOLECULAR WEIGHT; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; NEURITE OUTGROWTH; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PURKINJE CELL; SPEECH AND LANGUAGE; SUMOYLATION; TRANSCRIPTION REGULATION; VERBAL COMMUNICATION; ANIMAL; C57BL MOUSE; DENDRITE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOVEMENT (PHYSIOLOGY); PHYSIOLOGY; RIGHTING REFLEX; VOCALIZATION;

ANIMALS; CELL DIFFERENTIATION; CEREBELLUM; DENDRITES; FORKHEAD TRANSCRIPTION FACTORS; MICE; MICE, INBRED C57BL; MOVEMENT; PURKINJE CELLS; REFLEX, RIGHTING; REPRESSOR PROTEINS; SUMOYLATION; VOCALIZATION, ANIMAL;

EID: 84961282233     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2016.02.008     Document Type: Article

References (81)

1. 1 Lai, CS, Fisher, SE, Hurst, JA, Vargha-Khadem, F, Monaco, AP, A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 413 (2001), 519–523.
2. 2 Lepp, S, Anderson, A, Konopka, G, Connecting signaling pathways underlying communication to ASD vulnerability. Int Rev Neurobiol 113 (2013), 97–133.
3. 3 Usui, N, Co, M, Konopka, G, Decoding the molecular evolution of human cognition using comparative genomics. Brain Behav Evol 84 (2014), 103–116.
4. 4 Enard, W, Gehre, S, Hammerschmidt, K, Holter, SM, Blass, T, Somel, M, et al. A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell 137 (2009), 961–971.
5. 5 Reimers-Kipping, S, Hevers, W, Paabo, S, Enard, W, Humanized Foxp2 specifically affects cortico-basal ganglia circuits. Neuroscience 175 (2011), 75–84.
6. 6 Schreiweis, C, Bornschein, U, Burguiere, E, Kerimoglu, C, Schreiter, S, Dannemann, M, et al. Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance. Proc Natl Acad Sci U S A 111 (2014), 14253–14258.
7. 7 Vargha-Khadem, F, Gadian, DG, Copp, A, Mishkin, M, FOXP2 and the neuroanatomy of speech and language. Nat Rev Neurosci 6 (2005), 131–138.
8. 8 Shu, W, Cho, JY, Jiang, Y, Zhang, M, Weisz, D, Elder, GA, et al. Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci U S A 102 (2005), 9643–9648.
9. 9 French, CA, Groszer, M, Preece, C, Coupe, AM, Rajewsky, K, Fisher, SE, Generation of mice with a conditional Foxp2 null allele. Genesis 45 (2007), 440–446.
10. 10 Fujita, E, Tanabe, Y, Shiota, A, Ueda, M, Suwa, K, Momoi, MY, et al. Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells. Proc Natl Acad Sci U S A 105 (2008), 3117–3122.
11. 11 Groszer, M, Keays, DA, Deacon, RM, de Bono, JP, Prasad-Mulcare, S, Gaub, S, et al. Impaired synaptic plasticity and motor learning in mice with a point mutation implicated in human speech deficits. Curr Biol 18 (2008), 354–362.
12. 12 Wolf, U, Rapoport, MJ, Schweizer, TA, Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 21 (2009), 245–253.
13. 13 D'Angelo, E, Casali, S, Seeking a unified framework for cerebellar function and dysfunction: From circuit operations to cognition. Front Neural Circuits, 6, 2012, 116.
14. 14 Reeber, SL, Otis, TS, Sillitoe, RV, New roles for the cerebellum in health and disease. Front Syst Neurosci, 7, 2013, 83.
15. 15 Wang, SS, Kloth, AD, Badura, A, The cerebellum, sensitive periods, and autism. Neuron 83 (2014), 518–532.
16. 16 Koziol, LF, Budding, D, Andreasen, N, D'Arrigo, S, Bulgheroni, S, Imamizu, H, et al. Consensus paper: The cerebellum's role in movement and cognition. Cerebellum 13 (2014), 151–177.
17. 17 Marien, P, Ackermann, H, Adamaszek, M, Barwood, CH, Beaton, A, Desmond, J, et al. Consensus paper: Language and the cerebellum: An ongoing enigma. Cerebellum 13 (2014), 386–410.
18. 18 Hampson, DR, Blatt, GJ, Autism spectrum disorders and neuropathology of the cerebellum. Front Neurosci, 9, 2015, 420.
19. 19 Mosconi, MW, Wang, Z, Schmitt, LM, Tsai, P, Sweeney, JA, The role of cerebellar circuitry alterations in the pathophysiology of autism spectrum disorders. Front Neurosci, 9, 2015, 296.
20. 20 Tsai, PT, Hull, C, Chu, Y, Greene-Colozzi, E, Sadowski, AR, Leech, JM, et al. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488 (2012), 647–651.
21. 21 Gill, G, Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity. Curr Opin Genet Dev 13 (2003), 108–113.
22. 22 Henley, JM, Craig, TJ, Wilkinson, KA, Neuronal SUMOylation: Mechanisms, physiology, and roles in neuronal dysfunction. Physiol Rev 94 (2014), 1249–1285.
23. 23 Shalizi, A, Gaudilliere, B, Yuan, Z, Stegmuller, J, Shirogane, T, Ge, Q, et al. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311 (2006), 1012–1017.
24. 24 Wilkinson, KA, Nakamura, Y, Henley, JM, Targets and consequences of protein SUMOylation in neurons. Brain Res Rev 64 (2010), 195–212.
25. 25 Martin, S, Wilkinson, KA, Nishimune, A, Henley, JM, Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci 8 (2007), 948–959.
26. 26 Meredith, LJ, Wang, CM, Nascimento, L, Liu, R, Wang, L, Yang, WH, The key regulator for language and speech development, FOXP2, is a novel substrate for SUMOylation. J Cell Biochem 117 (2015), 426–438.
27. 27 Nishiyama, J, Hayashi, Y, Nomura, T, Miura, E, Kakegawa, W, Yuzaki, M, Selective and regulated gene expression in murine Purkinje cells by in utero electroporation. Eur J Neurosci 36 (2012), 2867–2876.
28. 28 dal Maschio, M, Ghezzi, D, Bony, G, Alabastri, A, Deidda, G, Brondi, M, et al. High-performance and site-directed in utero electroporation by a triple-electrode probe. Nat Commun, 3, 2012, 960.
29. 29 Franco, SJ, Gil-Sanz, C, Martinez-Garay, I, Espinosa, A, Harkins-Perry, SR, Ramos, C, et al. Fate-restricted neural progenitors in the mammalian cerebral cortex. Science 337 (2012), 746–749.
30. 30 Sia, GM, Clem, RL, Huganir, RL, The human language-associated gene SRPX2 regulates synapse formation and vocalization in mice. Science 342 (2013), 987–991.
31. 31 Bossis, G, Melchior, F, Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol Cell 21 (2006), 349–357.
32. 32 Fukuda, I, Ito, A, Hirai, G, Nishimura, S, Kawasaki, H, Saitoh, H, et al. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 16 (2009), 133–140.
33. 33 Sakai, Y, Shaw, CA, Dawson, BC, Dugas, DV, Al-Mohtaseb, Z, Hill, DE, et al. Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med, 3, 2011 86ra49.
34. 34 Sharrocks, AD, PIAS proteins and transcriptional regulation—more than just SUMO E3 ligases?. Genes Dev 20 (2006), 754–758.
35. 35 Geiss-Friedlander, R, Melchior, F, Concepts in sumoylation: A decade on. Nat Rev Mol Cell Biol 8 (2007), 947–956.
36. 36 Hasegawa, Y, Yoshida, D, Nakamura, Y, Sakakibara, S, Spatiotemporal distribution of SUMOylation components during mouse brain development. J Comp Neurol 522 (2014), 3020–3036.
37. 37 Vernes, SC, Oliver, PL, Spiteri, E, Lockstone, HE, Puliyadi, R, Taylor, JM, et al. Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS Genet, 7, 2011, e1002145.
38. 38 Chiu, YC, Li, MY, Liu, YH, Ding, JY, Yu, JY, Wang, TW, Foxp2 regulates neuronal differentiation and neuronal subtype specification. Dev Neurobiol 74 (2014), 723–738.
39. 39 Devanna, P, Middelbeek, J, Vernes, SC, FOXP2 drives neuronal differentiation by interacting with retinoic acid signaling pathways. Front Cell Neurosci, 8, 2014, 305.
40. 40 Ferland, RJ, Cherry, TJ, Preware, PO, Morrisey, EE, Walsh, CA, Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain. J Comp Neurol 460 (2003), 266–279.
41. 41 Takahashi, K, Liu, FC, Hirokawa, K, Takahashi, H, Expression of Foxp2, a gene involved in speech and language, in the developing and adult striatum. J Neurosci Res 73 (2003), 61–72.
42. 42 Fujita, H, Sugihara, I, FoxP2 expression in the cerebellum and inferior olive: Development of the transverse stripe-shaped expression pattern in the mouse cerebellar cortex. J Comp Neurol 520 (2012), 656–677.
43. 43 Silva, JM, Li, MZ, Chang, K, Ge, W, Golding, MC, Rickles, RJ, et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 37 (2005), 1281–1288.
44. 44 Dastjerdi, FV, Consalez, GG, Hawkes, R, Pattern formation during development of the embryonic cerebellum. Front Neuroanat, 6, 2012, 10.
45. 45 Vernes, SC, Newbury, DF, Abrahams, BS, Winchester, L, Nicod, J, Groszer, M, et al. A functional genetic link between distinct developmental language disorders. N Engl J Med 359 (2008), 2337–2345.
46. 46 Li, S, Weidenfeld, J, Morrisey, EE, Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol Cell Biol 24 (2004), 809–822.
47. 47 Lin, X, Sun, B, Liang, M, Liang, YY, Gast, A, Hildebrand, J, et al. Opposed regulation of corepressor CtBP by SUMOylation and PDZ binding. Mol Cell 11 (2003), 1389–1396.
48. 48 Konopka, G, Bomar, JM, Winden, K, Coppola, G, Jonsson, ZO, Gao, F, et al. Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature 462 (2009), 213–217.
49. 49 Penagarikano, O, Geschwind, DH, What does CNTNAP2 reveal about autism spectrum disorder?. Trends Mol Med 18 (2012), 156–163.
50. 50 Chiocchetti, AG, Kopp, M, Waltes, R, Haslinger, D, Duketis, E, Jarczok, TA, et al. Variants of the CNTNAP2 5′ promoter as risk factors for autism spectrum disorders: A genetic and functional approach. Mol Psychiatry 20 (2015), 839–849.
51. 51 Anderson, GR, Galfin, T, Xu, W, Aoto, J, Malenka, RC, Sudhof, TC, Candidate autism gene screen identifies critical role for cell-adhesion molecule CASPR2 in dendritic arborization and spine development. Proc Natl Acad Sci U S A 109 (2012), 18120–18125.
52. 52 Penagarikano, O, Abrahams, BS, Herman, EI, Winden, KD, Gdalyahu, A, Dong, H, et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147 (2011), 235–246.
53. 53 Fujita-Jimbo, E, Momoi, T, Specific expression of FOXP2 in cerebellum improves ultrasonic vocalization in heterozygous but not in homozygous Foxp2 (R552H) knock-in pups. Neurosci Lett 566 (2014), 162–166.
54. 54 Buttermore, ED, Piochon, C, Wallace, ML, Philpot, BD, Hansel, C, Bhat, MA, Pinceau organization in the cerebellum requires distinct functions of neurofascin in Purkinje and basket neurons during postnatal development. J Neurosci 32 (2012), 4724–4742.
55. 55 Stielow, C, Stielow, B, Finkernagel, F, Scharfe, M, Jarek, M, Suske, G, SUMOylation of the polycomb group protein L3MBTL2 facilitates repression of its target genes. Nucl Acids Res 42 (2014), 3044–3058.
56. 56 Klockgether, T, Sporadic ataxia with adult onset: Classification and diagnostic criteria. Lancet Neurol 9 (2010), 94–104.
57. 57 Becker, EB, Stoodley, CJ, Autism spectrum disorder and the cerebellum. Int Rev Neurobiol 113 (2013), 1–34.
58. 58 Palmen, SJ, van Engeland, H, Hof, PR, Schmitz, C, Neuropathological findings in autism. Brain 127 (2004), 2572–2583.
59. 59 Reyes, MG, Gordon, A, Cerebellar vermis in schizophrenia. Lancet 2 (1981), 700–701.
60. 60 Tran, KD, Smutzer, GS, Doty, RL, Arnold, SE, Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry 155 (1998), 1288–1290.
61. 61 Ichimiya, T, Okubo, Y, Suhara, T, Sudo, Y, Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia. Biol Psychiatry 49 (2001), 20–27.
62. 62 Ramnani, N, The primate cortico-cerebellar system: anatomy and function. Nat Rev Neurosci 7 (2006), 511–522.
63. 63 Scattoni, ML, Crawley, J, Ricceri, L, Ultrasonic vocalizations: A tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev 33 (2009), 508–515.
64. 64 Araujo, DJ, Anderson, AG, Berto, S, Runnels, W, Harper, M, Ammanuel, S, et al. FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. Genes Dev 29 (2015), 2081–2096.
65. 65 Young, DM, Schenk, AK, Yang, SB, Jan, YN, Jan, LY, Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism. Proc Natl Acad Sci U S A 107 (2010), 11074–11079.
66. 66 Radyushkin, K, Hammerschmidt, K, Boretius, S, Varoqueaux, F, El-Kordi, A, Ronnenberg, A, et al. Neuroligin-3-deficient mice: Model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav 8 (2009), 416–425.
67. 67 Jamain, S, Radyushkin, K, Hammerschmidt, K, Granon, S, Boretius, S, Varoqueaux, F, et al. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A 105 (2008), 1710–1715.
68. 68 Wohr, M, Roullet, FI, Hung, AY, Sheng, M, Crawley, JN, Communication impairments in mice lacking Shank1: Reduced levels of ultrasonic vocalizations and scent marking behavior. PloS One, 6, 2011, e20631.
69. 69 Won, H, Lee, HR, Gee, HY, Mah, W, Kim, JI, Lee, J, et al. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486 (2012), 261–265.
70. 70 Yang, M, Bozdagi, O, Scattoni, ML, Wohr, M, Roullet, FI, Katz, AM, et al. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci 32 (2012), 6525–6541.
71. 71 Picker, JD, Yang, R, Ricceri, L, Berger-Sweeney, J, An altered neonatal behavioral phenotype in Mecp2 mutant mice. Neuroreport 17 (2006), 541–544.
72. 72 Lee, L, Dale, E, Staniszewski, A, Zhang, H, Saeed, F, Sakurai, M, et al. Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease. Sci Rep, 4, 2014, 7190.
73. 73 Chen, YC, Hsu, WL, Ma, YL, Tai, DJ, Lee, EH, CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory. J Neurosci 34 (2014), 9574–9589.
74. 74 Wang, L, Rodriguiz, RM, Wetsel, WC, Sheng, H, Zhao, S, Liu, X, et al. Neuron-specific Sumo1-3 knockdown in mice impairs episodic and fear memories. J Psychiatry Neurosci 39 (2014), 259–266.
75. 75 Toro, R, Konyukh, M, Delorme, R, Leblond, C, Chaste, P, Fauchereau, F, et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 26 (2010), 363–372.
76. 76 Delorme, R, Ey, E, Toro, R, Leboyer, M, Gillberg, C, Bourgeron, T, Progress toward treatments for synaptic defects in autism. Nat Med 19 (2013), 685–694.
77. 77 Flavell, SW, Cowan, CW, Kim, TK, Greer, PL, Lin, Y, Paradis, S, et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311 (2006), 1008–1012.
78. 78 Chao, HW, Hong, CJ, Huang, TN, Lin, YL, Hsueh, YP, SUMOylation of the MAGUK protein CASK regulates dendritic spinogenesis. J Cell Biol 182 (2008), 141–155.
79. 79 Cheng, J, Huang, M, Zhu, Y, Xin, YJ, Zhao, YK, Huang, J, et al. SUMOylation of MeCP2 is essential for transcriptional repression and hippocampal synapse development. J Neurochem 128 (2014), 798–806.
80. 80 Craig, TJ, Henley, JM, Protein SUMOylation in spine structure and function. Curr Opin Neurobiol 22 (2012), 480–487.
81. 81 Qi, Y, Wang, J, Bomben, VC, Li, DP, Chen, SR, Sun, H, et al. Hyper-SUMOylation of the Kv7 potassium channel diminishes the M-current leading to seizures and sudden death. Neuron 83 (2014), 1159–1171.